The Center for Science in the Public Interest submitted formal petitions to both Food and Drug Administration and the Federal Trade Commission in December to halt labeling and advertising claims that garlic supplements reduce cholesterol by some manufacturers of dietary supplements.
E-BOOK SPECIAL REPORT
44 Best Package Designs: 2015
Sign up to receive timely updates from our editors and download this e-book of our editors’ selections for most innovative package designs of the past year.
The Food and Drug Administration (FDA) has proposed a 120-day premarket notification for biotech foods in which manufacturers would provide the FDA with information demonstrating that the product is as safe as its conventional counterpart.
The Center for Science in the Public Interest (CSPI), a Washington, DC-based consumer activist group, is calling on the FDA to halt the sale of dozens of functional foods it says contain ingredients not considered safe by the agency.
FDA has given the green light to a health claim on food labels that states Diets containing foods that are good sources of potassium and low in sodium may reduce the risk of high blood pressure and stroke.
The U.S. Court of Appeals ruled in 1999 that the Food and Drug Administration should consider allowing health claims on dietary supplements even though they are not widely recognized as valid by the scientific community.